GlaxoSmithKline makes bold move with £130m Covid-19 investment | Nils Pratley

  • 📰 The Guardian
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 53%

Business Business Headlines News

Business Business Latest News,Business Business Headlines

GSK’s share price has been left standing by AstraZeneca’s high-risk success in cancer treatments

Monday’s most important vaccine news was the promising early data from the Oxford University and AstraZeneca coronavirus trial – “robust immune responses” is encouraging. But let’s not overlook other vaccine developments. The industry has been viewed for years as a dull subsector of the pharmaceutical business; now it is a whir of deal-making activity.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Bold? With Lord Backsheesh Of Durham At Barnham Castle?

Fuck your poison dart. We know the shite that is in it. The people are waking up!

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 84. in BUSİNESS

Business Business Latest News, Business Business Headlines